Filing Details
- Accession Number:
- 0001815776-24-000046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-15 16:13:06
- Reporting Period:
- 2024-05-14
- Accepted Time:
- 2024-05-15 16:13:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1815776 | Lenz Therapeutics Inc. | LENZ | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1706176 | R. Daniel Chevallard | C/O Lenz Therapeutics, Inc. 445 Marine View Ave Suite 320 Del Mar CA 92014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-14 | 3,188 | $15.68 | 3,188 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
